Unique Ingredient Identifier 46N107B71O is listed as a ingredient substance
| RN | 9000-59-3 |
| EC | 232-549-9 |
| NCIT | C66001 |
| RXCUI | 1368898 |
| NCBI | 473130 |
UNII 46N107B71O SHELLAC is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 330.88 MG |
| ORAL | CAPSULE, COATED PELLETS | 0.43 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.063 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 0.02 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 29 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.0783 MG |
| ORAL | CAPSULE, SOFT GELATIN | NA |
| ORAL | CAPSULE, SUSTAINED ACTION | 75.01 MG |
| ORAL | TABLET | 24.04 MG |
| ORAL | TABLET, COATED | 15.2 MG |
| ORAL | TABLET, DELAYED ACTION | 0.22 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 21.44 MG |
| ORAL | TABLET, EXTENDED RELEASE | 1.24 MG |
| ORAL | TABLET, FILM COATED | 4.4 MG |
| ORAL | TABLET, SUSTAINED ACTION | 213.24 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |
| SUBLINGUAL | FILM | QS |
| SUBLINGUAL | FILM | PNG |